Compound ID | 731
Class: Aminoglycoside
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Use against CAP and gastrointestinal infections. Spectinomycin analog with greater potency than its parent molecule |
Description: | Novak, E., et al. "Safety and preliminary pharmacokinetics of intravenously administered trospectomycin sulfate (U-63,366 F) in man: a novel spectinomycin analogue [abstr 271]." 27th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). 1987. |
Institute where first reported: | Pharmacia&Upjohn (Pfizer, US) |
Year first mentioned: | 1984 |
Highest developmental phase: | Phase 3 |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/55886 |
Guide to Pharmacology: | trospectomycin |
Citations: |
|